NERV

Minerva Neurosciences, Inc.

Price Chart

No historical data available

Latest Quote

$4.56

-0.28 (-5.79%)

Current Price

Previous Close	$4.84
Open	$4.88
Day High	$4.88
Day Low	$4.52
Volume	116,330

Fetched: 2026-09-01T02:53:49

Stock Information

Shares Outstanding	47.75M
Total Debt	$60.00M
Cash Equivalents	$75.27M
Net Income	$-394.35M
Sector	Healthcare
Industry	Biotechnology
Market Cap	$217.73M
EPS (TTM)	$-36.12
Exchange	NCM

🌐 Visit Website

Recent Price History

No history data available. Data will be fetched automatically.

About Minerva Neurosciences, Inc.

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, which is in Phase 3 confirmatory trial for the treatment of negative symptoms in patients with schizophrenia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.

📰 Latest News

No news articles available at the moment. Check back later for updates on NERV.

Period:

Income Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue
Total Revenue	$0	$0	$0	$0
Operating Revenue	$0	$0	$0	$0
Expenses
Interest Expense	$0	$4,562,223	$8,282,947	$7,406,555
Total Expenses	$15,102,970	$21,848,386	$23,119,576	$25,231,326
Other Income Expense	$-275,217,558	$27,849,474	$1,397,170	$529,205
Other Non Operating Income Expenses	$-321,499,041	$26,579,046	-	-
Net Non Operating Interest Income Expense	$-3,102,649	$-4,562,223	$-8,282,947	$-7,406,555
Total Other Finance Cost	$3,102,649	-	-	-
Interest Expense Non Operating	$0	$4,562,223	$8,282,947	$7,406,555
Operating Expense	$15,102,970	$21,848,386	$23,119,576	$25,231,326
General And Administrative Expense	$9,343,497	$9,949,791	$10,414,323	$10,582,239
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$-293,423,177	$1,438,865	$-30,005,353	$-32,108,676
Net Interest Income	$-3,102,649	$-4,562,223	$-8,282,947	$-7,406,555
Normalized Income	$-339,704,660	$168,437	$-31,402,523	$-32,637,881
Net Income From Continuing And Discontinued Operation	$-293,423,177	$1,438,865	$-30,005,353	$-32,108,676
Total Operating Income As Reported	$-15,102,970	$-21,848,386	$-23,119,576	$-25,231,326
Net Income Common Stockholders	$-293,423,177	$1,438,865	$-30,005,353	$-32,108,676
Net Income	$-293,423,177	$1,438,865	$-30,005,353	$-32,108,676
Net Income Including Noncontrolling Interests	$-293,423,177	$1,438,865	$-30,005,353	$-32,108,676
Net Income Continuous Operations	$-293,423,177	$1,438,865	$-30,005,353	$-32,108,676
Pretax Income	$-293,423,177	$1,438,865	$-30,005,353	$-32,108,676
Operating Income	$-15,102,970	$-21,848,386	$-23,119,576	$-25,231,326
Interest Income	-	-	$1,437,405	$556,946
Interest Income Non Operating	-	-	$1,437,405	$556,946
Per Share
Diluted EPS	$-34.67	$0.19	$-4.61	$-6.01
Basic EPS	$-34.67	$0.19	$-4.61	$-6.01
Other
Tax Effect Of Unusual Items	$0	$0	$0	$0
Tax Rate For Calcs	$0	$0	$0	$0
Normalized EBITDA (Bullshit earnings)	$-339,699,218	$4,753,129	$-23,088,594	$-25,222,813
Total Unusual Items	$46,281,483	$1,270,428	$1,397,170	$529,205
Total Unusual Items Excluding Goodwill	$46,281,483	$1,270,428	$1,397,170	$529,205
Reconciled Depreciation	$5,442	$22,469	$30,982	$8,513
EBITDA (Bullshit earnings)	$-293,417,735	$6,023,557	$-21,691,424	$-24,693,608
EBIT	$-293,423,177	$6,001,088	$-21,722,406	$-24,702,121
Diluted Average Shares	$8,464,000	$7,573,763	$6,506,372	$5,340,194
Basic Average Shares	$8,464,000	$7,568,981	$6,506,372	$5,340,194
Diluted NI Availto Com Stockholders	$-293,423,177	$1,438,865	$-30,005,353	$-32,108,676
Gain On Sale Of Security	$46,281,483	$1,270,428	$1,397,170	$529,205
Research And Development	$5,759,473	$11,898,595	$12,705,253	$14,649,087
Selling General And Administration	$9,343,497	$9,949,791	$10,414,323	$10,582,239
Other Gand A	$9,343,497	$9,949,791	$10,414,323	$10,582,239
Tax Provision	-	-	-	$0

Fetched: 2026-09-01

Balance Sheet (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Net Tangible Assets	$-155,617,481	$-40,562,499	$-43,343,916	$-34,936,185
Total Assets	$97,968,888	$37,143,744	$56,899,750	$55,087,233
Total Non Current Assets	$14,869,399	$14,874,841	$14,897,310	$14,928,292
Goodwill And Other Intangible Assets	$14,869,399	$14,869,399	$14,886,426	$14,911,966
Current Assets	$83,099,489	$22,268,903	$42,002,440	$40,158,941
Other Current Assets	$697,676	$806,895	$989,865	$3,965,335
Restricted Cash	$100,000	$100,000	$100,000	$100,000
Cash Cash Equivalents And Short Term Investments	$82,301,813	$21,362,008	$40,912,575	$36,093,606
Cash And Cash Equivalents	$82,301,813	$21,362,008	$40,912,575	$36,093,606
Other Intangible Assets	-	-	$17,027	$42,567
Prepaid Assets	-	-	-	-
Debt
Total Debt	-	-	-	-
Liabilities
Total Liabilities Net Minority Interest	$238,716,970	$62,836,844	$85,357,240	$75,111,452
Total Non Current Liabilities Net Minority Interest	$236,426,497	$60,000,000	$82,016,823	$73,733,876
Other Non Current Liabilities	$60,000,000	$60,000,000	$82,016,823	$73,733,876
Derivative Product Liabilities	$171,464,575	$0	-	-
Current Liabilities	$2,290,473	$2,836,844	$3,340,417	$1,377,576
Payables And Accrued Expenses	$2,290,473	$2,473,663	$2,749,648	$1,362,744
Payables	$639,707	$1,607,844	$1,805,320	$969,667
Accounts Payable	$639,707	$1,607,844	$1,805,320	$969,667
Non Current Deferred Liabilities	-	-	-	-
Non Current Deferred Taxes Liabilities	-	-	-	-
Equity
Common Stock Equity	$-140,748,082	$-25,693,100	$-28,457,490	$-20,024,219
Total Equity Gross Minority Interest	$-140,748,082	$-25,693,100	$-28,457,490	$-20,024,219
Stockholders Equity	$-140,748,082	$-25,693,100	$-28,457,490	$-20,024,219
Retained Earnings	$-688,799,740	$-395,376,563	$-396,815,428	$-366,810,075
Preferred Securities Outside Stock Equity	$4,961,922	$0	-	-
Other
Ordinary Shares Number	$43,274,398	$6,993,406	$6,993,406	$5,340,193
Share Issued	$43,274,398	$6,993,406	$6,993,406	$5,340,193
Tangible Book Value	$-155,617,481	$-40,562,499	$-43,343,916	$-34,936,185
Invested Capital	$-140,748,082	$-25,693,100	$-28,457,490	$-20,024,219
Working Capital	$80,809,016	$19,432,059	$38,662,023	$38,781,365
Total Capitalization	$-140,748,082	$-25,693,100	$-28,457,490	$-20,024,219
Additional Paid In Capital	$548,047,331	$369,682,764	$368,357,239	$346,785,322
Capital Stock	$4,327	$699	$699	$534
Common Stock	$4,327	$699	$699	$534
Pensionand Other Post Retirement Benefit Plans Current	$0	$363,181	$590,769	$14,832
Current Accrued Expenses	$1,650,766	$865,819	$944,328	$393,077
Goodwill	$14,869,399	$14,869,399	$14,869,399	$14,869,399
Net PPE	$0	$5,442	$10,884	$16,326
Preferred Stock	-	$0	$0	$0
Gross PPE	-	-	-	$16,326
Other Properties	-	-	-	$16,326
Capital Lease Obligations	-	-	-	-
Current Capital Lease Obligation	-	-	-	-
Buildings And Improvements	-	-	-	-
Properties	-	-	-	-

Fetched: 2026-09-01

Cash Flow Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Free Cash Flow
Free Cash Flow	$-13,510,936	$-19,550,567	$-14,784,732	$-24,661,469
Operating Activities
Operating Cash Flow	$-13,510,936	$-19,550,567	$-14,784,732	$-24,645,143
Cash Flow From Continuing Operating Activities	$-13,510,936	$-19,550,567	$-14,784,732	$-24,645,143
Operating Gains Losses	$279,211,774	-	-	-
Investing Activities
Investing Cash Flow	$0	$0	$0	$-16,326
Cash Flow From Continuing Investing Activities	-	-	$0	$-16,326
Capital Expenditure	-	-	-	$-16,326
Financing Activities
Issuance Of Capital Stock	$80,000,000	$0	$19,999,994	$0
Financing Cash Flow	$74,450,741	$0	$19,603,701	$-5
Cash Flow From Continuing Financing Activities	$74,450,741	$0	$19,603,701	$-5
Net Other Financing Charges	$-5,549,259	-	$-396,293	$-5
Net Preferred Stock Issuance	$80,000,000	$0	-	-
Preferred Stock Issuance	$80,000,000	$0	-	-
Net Common Stock Issuance	-	$0	$19,999,994	$0
Common Stock Issuance	-	$0	$19,999,994	$0
Other
End Cash Position	$82,401,813	$21,462,008	$41,012,575	$36,193,606
Beginning Cash Position	$21,462,008	$41,012,575	$36,193,606	$60,855,080
Changes In Cash	$60,939,805	$-19,550,567	$4,818,969	$-24,661,474
Change In Working Capital	$-632,347	$-320,603	$4,938,311	$-4,060,354
Change In Payables And Accrued Expense	$-741,566	$-503,573	$1,962,841	$-1,441,378
Change In Accrued Expense	$317,446	$-306,097	$1,127,188	$-557,830
Change In Payable	$-1,059,012	$-197,476	$835,653	$-883,548
Change In Account Payable	$-1,059,012	$-197,476	$835,653	$-883,548
Change In Prepaid Assets	$109,219	$182,970	$-141,748	$498,242
Stock Based Compensation	$1,327,372	$1,325,525	$1,968,381	$4,108,819
Depreciation Amortization Depletion	$5,442	$22,469	$30,982	$8,513
Depreciation And Amortization	$5,442	$22,469	$30,982	$8,513
Amortization Cash Flow	$0	$17,027	$25,540	$8,513
Amortization Of Intangibles	$0	$17,027	$25,540	$8,513
Depreciation	$5,442	$5,442	$5,442	$0
Gain Loss On Investment Securities	$279,211,774	-	-	-
Net Income From Continuing Operations	$-293,423,177	$1,438,865	$-30,005,353	$-32,108,676
Change In Other Current Assets	-	$0	$3,117,218	$-3,117,218
Other Non Cash Items	-	$-22,016,823	$8,282,947	$7,406,555
Net PPE Purchase And Sale	-	-	$0	$-16,326
Purchase Of PPE	-	-	$0	$-16,326
Change In Other Working Capital	-	-	-	$-3,117,218
Change In Other Current Liabilities	-	-	-	$0
Asset Impairment Charge	-	-	-	$0
Interest Paid Supplemental Data	-	-	-	-
Proceeds From Stock Option Exercised	-	-	-	-
Net Investment Purchase And Sale	-	-	-	-
Sale Of Investment	-	-	-	-
Purchase Of Investment	-	-	-	-
Amortization Of Securities	-	-	-	-
Deferred Tax	-	-	-	-
Deferred Income Tax	-	-	-	-

Fetched: 2026-09-01